Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

An Open Label Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon (PF 01913539) In Patients With Alzheimer's Disease

NCT00939783 is registered in ClinicalTrials.gov with Pfizer as lead sponsor.

NCT NCT00939783
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00939783 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
An Open Label Extension To The B1451027 Protocol To Evaluate The Long Term Safety And Tolerability Of Dimebon (PF 01913539) In Patients With Alzheimer's Disease
Lead sponsor
Pfizer
Phase
Phase 3
Overall status
Terminated
Start date
September 30, 2009
Completion date
August 31, 2010
Enrollment
649 (actual)
Sites
105

Conditions

As the registry lists them; a condition with its own page is linked.

alzheimer's disease